Clinical Trials for Mersana Therapeutics

Explore 3 clinical trials worldwide

Showing 1-3 of 3 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Mersana Therapeutics

Clinical Trials (3)

NCT05514717
A Study of XMT-2056 in Advanced/Recurrent Solid Tumors That Express HER2
PHASE1Recruiting
162 participants
Started: Jan 24, 2023 · Completed: Apr 30, 2027
6 conditions1 sponsor14 locations
NCT05377996
A Study of XMT-1660 in Participants With Solid Tumors
PHASE1Recruiting
319 participants
Started: Aug 15, 2022 · Completed: May 31, 2027
7 conditions1 sponsor23 locations
NCT03319628
First-in-Human Study of XMT-1536 in Cancers Likely to Express NaPi2b
PHASE1/PHASE2Active, not recruiting
523 participants
Started: Dec 12, 2017 · Completed: Oct 31, 2024
2 conditions1 sponsor1 location